ClinicalTrialsFinder

EGFR Exon 20 Insertion Mutation Clinical Trials in Bordeaux

1 recruitingBordeaux, France

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

Non-small Cell Lung CancerEGFR Exon 20 Insertion Mutation
Groupe Francais De Pneumo-Cancerologie30 enrolled18 locationsNCT06247826